SUBPART B—Labeling Requirements for Prescription Drugs and/or Insulin (§201.50 to §201.58)
- 201.50—Statement of identity.
- 201.51—Declaration of net quantity of contents.
- 201.55—Statement of dosage.
- 201.56—Requirements on content and format of labeling for human prescription drug and biological products.
- 201.57—Specific requirements on content and format of labeling for human prescription drug and biological products described in § 201.56(b)(1).
- 201.58—Waiver of labeling requirements.